1. Home
  2. CACC vs LEGN Comparison

CACC vs LEGN Comparison

Compare CACC & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Credit Acceptance Corporation

CACC

Credit Acceptance Corporation

HOLD

Current Price

$498.26

Market Cap

5.2B

Sector

Finance

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$17.34

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CACC
LEGN
Founded
1972
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.9B
IPO Year
1992
2020

Fundamental Metrics

Financial Performance
Metric
CACC
LEGN
Price
$498.26
$17.34
Analyst Decision
Hold
Buy
Analyst Count
2
14
Target Price
$485.00
$64.23
AVG Volume (30 Days)
162.2K
3.1M
Earning Date
01-29-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
151.44
N/A
EPS
37.89
N/A
Revenue
$1,232,900,000.00
$909,045,000.00
Revenue This Year
$154.47
$67.56
Revenue Next Year
$1.57
$45.77
P/E Ratio
$13.15
N/A
Revenue Growth
45.72
74.75
52 Week Low
$401.90
$17.03
52 Week High
$560.00
$45.30

Technical Indicators

Market Signals
Indicator
CACC
LEGN
Relative Strength Index (RSI) 64.97 28.22
Support Level $431.71 $20.21
Resistance Level $454.52 $19.28
Average True Range (ATR) 16.51 1.18
MACD 1.69 -0.34
Stochastic Oscillator 98.50 5.61

Price Performance

Historical Comparison
CACC
LEGN

About CACC Credit Acceptance Corporation

Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: